Fidelity SPDR Advertisement
Home > Boards > US Listed > Medical - Equipment > Navidea Biopharmaceuticals, Inc. (NAVB)

The old timers on IV sometimes have rose

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
sts66 Member Profile
 
Followed By 23
Posts 3,587
Boards Moderated 0
Alias Born 04/26/10
160x600 placeholder
Navidea to Participate in the BTIG Emerging Technologies in Healthcare Diagnostics Investor Conference September 30th "Business Wire" - 9/29/2014 3:36:00 PM
Navidea’s Lymphoseek® Recommended by CHMP for European Approval in Sentinel Lymph Node Detection for Melanoma, Breast & Ce... "Business Wire" - 9/26/2014 7:27:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 9/24/2014 4:40:16 PM
Navidea Awarded $1.67M Fast Track NIH SBIR Grant for Evaluation of Lymphoseek® in Cervical Cancer "Business Wire" - 9/23/2014 7:30:00 AM
Navidea Receives Orphan Drug Designation from FDA for Use of Lymphoseek® in Head and Neck Cancers "Business Wire" - 9/18/2014 4:07:00 PM
Post-effective Amendment to an S-8 Filing (s-8 Pos) "Edgar (US Regulatory)" - 9/16/2014 12:31:06 PM
Securities Registration: Employee Benefit Plan (s-8) "Edgar (US Regulatory)" - 9/12/2014 4:11:24 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 9/10/2014 10:16:54 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 9/4/2014 5:54:05 PM
Navidea Enters Lymphoseek® Development and Commercialization Agreement for China "Business Wire" - 9/4/2014 7:30:00 AM
Initial Statement of Beneficial Ownership (3) "Edgar (US Regulatory)" - 8/22/2014 7:06:00 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 8/11/2014 4:07:13 PM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 8/11/2014 3:54:17 PM
Navidea Announces Second Quarter 2014 Financial Results; Total Revenues Grow to $1.1 Million "Business Wire" - 8/6/2014 7:30:00 AM
Navidea Biopharmaceuticals to Announce Second Quarter 2014 Financial Results on August 6, 2014 "Business Wire" - 7/29/2014 9:37:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 7/21/2014 5:18:04 PM
Navidea Biopharmaceuticals Announces 2014 Annual Meeting Results "Business Wire" - 7/17/2014 3:44:00 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 7/16/2014 4:08:06 PM
Navidea Joins Essex Woodland’s Rheumco to Develop Radiopharmaceuticals for Detection and Treatment of Arthritic Diseases "Business Wire" - 7/16/2014 7:30:00 AM
Navidea Biopharmaceuticals to Present at the 9th Annual JMP Securities Healthcare Conference "Business Wire" - 6/17/2014 4:30:00 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 6/16/2014 3:51:13 PM
U.S. FDA Approves Navidea Biopharmaceuticals’ Lymphoseek® (technetium Tc 99m tilmanocept) Injection for Expanded Use in He... "Business Wire" - 6/13/2014 12:26:00 PM
Navidea Biopharmaceuticals’ Lymphoseek® (technetium Tc 99m tilmanocept) Injection Demonstrates Preferential Accumulation i... "Business Wire" - 6/11/2014 7:30:00 AM
Navidea Biopharmaceuticals Announces Positive Lymphoseek® (technetium Tc 99m tilmanocept) Injection Results on Injection Tim... "Business Wire" - 6/10/2014 4:30:00 PM
Navidea Announces Data Demonstrating Potential of Manocept™ Platform to Diagnose Rheumatoid Arthritis and Kaposi’s Sarcoma "Business Wire" - 6/10/2014 8:00:00 AM
sts66   Wednesday, 04/24/13 08:06:49 PM
Re: hondadriver1973 post# 3569
Post # of 7113 
The old timers on IV sometimes have rose colored glasses on....they refuse to see manipulation.....being shorted by firms supposedly investing in NAVB....even the words "basher" or similar are not allowed by DDB....this just doesn't smell right to me.....and JPM apparently bought some for a 2nd unnamed investor again, same thing as last time....who are these mystery buyers and why are their names being kept a secret?

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist